Yifan Shi
Yifan Shi has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Wenshe Ray Liu
Texas A&M University
2 shared publications - Alan Pham
Texas A&M University
1 shared publication - Guoqing Jin
Department of Chemistry, Texas A&M University, College Station, USA
1 shared publication - Saibal Chanda
Department of Biochemistry and Biophysics, College of Agriculture and Life Sciences
1 shared publication Sandeep Atla
Texas A&M Drug Discovery Center and Department of Chemistry, College of Arts and Sciences
1 shared publicationShivangi Sharma
Texas A&M Drug Discovery Center and Department of Chemistry, College of Arts and Sciences
1 shared publication
Latest Publications
- Open Access
- 26 September 2025
- Published by American Chemical Society (ACS) in Accounts of Chemical Research
- Vol. 58 (19) , 2985-2996
Advancing Genetically Encoded Lysine (GEK) Chemistry: From Precision Modulation to Therapeutic Innovation
ConspectusGenetically encoded lysine (GEK) chemistry has transformed protein engineering by enabling precise and site-specific modifications, which expand lysine's functional landscape beyond its native post-translational modifications (PTMs). Our work has systematically advanced GEK chemistry by developing engineered pyrrolysyl-tRNA synthetase (PylRS) variants that efficiently incorporate diverse lysine (Lys) derivatives with tailored chemical reactivity. By integrating bioorthogonal handles, acyl and electrophilic warheads, photo-cross-linking groups, and PTM mimics, we have established a set of powerful toolkits for protein labeling, functional studies, and Lys-directed drug design. These advances provide precise control over protein structure and function, facilitating the study of epigenetic modifications, enzyme-substrate interactions, and Lys-guided inhibitor development. As GEK chemistry continues to evolve, its integration with structural/synthetic biology and therapeutic innovation will further expand its impact, unlocking new frontiers in chemical biology and precision therapeutics.
- 26 September 2025
- Published by American Chemical Society (ACS) in Accounts of Chemical Research
- Vol. 58 (19) , 2985-2996
Open AccessAdvancing Genetically Encoded Lysine (GEK) Chemistry: From Precision Modulation to Therapeutic Innovation
ConspectusGenetically encoded lysine (GEK) chemistry has transformed protein engineering by enabling precise and site-specific modifications, which expand lysine's functional landscape beyond its native post-translational modifications (PTMs). Our work has systematically advanced GEK chemistry by developing engineered pyrrolysyl-tRNA synthetase (PylRS) variants that efficiently incorporate diverse lysine (Lys) derivatives with tailored chemical reactivity. By integrating bioorthogonal handles, acyl and electrophilic warheads, photo-cross-linking groups, and PTM mimics, we have established a set of powerful toolkits for protein labeling, functional studies, and Lys-directed drug design. These advances provide precise control over protein structure and function, facilitating the study of epigenetic modifications, enzyme-substrate interactions, and Lys-guided inhibitor development. As GEK chemistry continues to evolve, its integration with structural/synthetic biology and therapeutic innovation will further expand its impact, unlocking new frontiers in chemical biology and precision therapeutics.
- Open Access
- 13 August 2025
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 20 (9) , 2075-2080
A Simple, Quick, and Scalable Route to Fluorogenic Ubiquitin and Ubiquitin-Like Protein Substrates for Assessing Activities of Deubiquitinases and Ubiquitin-Like Protein-Specific Proteases
Ubiquitin (Ub) and ubiquitin-like proteins (UBLs) regulate essential cellular processes as protein modifiers. While Ub signaling is well studied, many UBL pathways remain poorly defined, partly due to the limited availability of suitable UBL substrates. Here, we report the synthesis of fluorogenic Ub-ACA and UBL-ACA probes using the activated cysteine-based protein ligation (ACPL) technique to conjugate recombinant Ub and UBLs containing a C-terminal Gly to Cys mutation with glycyl-2-(7-amino-2-oxo-2H-chromen-4-yl)acetic acid (Gly-ACA), a water-soluble fluorophore. This one-step strategy that allows replacing Cys with Gly-ACA enables simple, quick, and scalable synthesis of Ub-ACA and 11 UBL-ACAs. Five UBL-ACAs represent the first reported fluorogenic substrates for their respective UBLs. Afforded Ub-ACA and 10 UBL-ACAs were demonstrated to be active toward a panel of DUBs or UBL-specific proteases. Notably, SUMO4-ACA was cleaved by SENP1 with efficiency comparable to the other three SUMO-ACA probes despite SUMO4's distinct structure compared to the other three SUMOs. In human cell lysates, all 12 probes are efficiently cleaved. URM1 has no known proteases. Our results indicate that URM1-specific protease(s) exist in human cells and are yet to be identified. Given their simple and scalable synthesis, these new fluorogenic Ub-ACA and UBL-ACA substrates are highly versatile tools for studying Ub and UBL pathways and drug discovery research.
- 13 August 2025
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 20 (9) , 2075-2080
Open AccessA Simple, Quick, and Scalable Route to Fluorogenic Ubiquitin and Ubiquitin-Like Protein Substrates for Assessing Activities of Deubiquitinases and Ubiquitin-Like Protein-Specific Proteases
Ubiquitin (Ub) and ubiquitin-like proteins (UBLs) regulate essential cellular processes as protein modifiers. While Ub signaling is well studied, many UBL pathways remain poorly defined, partly due to the limited availability of suitable UBL substrates. Here, we report the synthesis of fluorogenic Ub-ACA and UBL-ACA probes using the activated cysteine-based protein ligation (ACPL) technique to conjugate recombinant Ub and UBLs containing a C-terminal Gly to Cys mutation with glycyl-2-(7-amino-2-oxo-2H-chromen-4-yl)acetic acid (Gly-ACA), a water-soluble fluorophore. This one-step strategy that allows replacing Cys with Gly-ACA enables simple, quick, and scalable synthesis of Ub-ACA and 11 UBL-ACAs. Five UBL-ACAs represent the first reported fluorogenic substrates for their respective UBLs. Afforded Ub-ACA and 10 UBL-ACAs were demonstrated to be active toward a panel of DUBs or UBL-specific proteases. Notably, SUMO4-ACA was cleaved by SENP1 with efficiency comparable to the other three SUMO-ACA probes despite SUMO4's distinct structure compared to the other three SUMOs. In human cell lysates, all 12 probes are efficiently cleaved. URM1 has no known proteases. Our results indicate that URM1-specific protease(s) exist in human cells and are yet to be identified. Given their simple and scalable synthesis, these new fluorogenic Ub-ACA and UBL-ACA substrates are highly versatile tools for studying Ub and UBL pathways and drug discovery research.